Explore more publications!

Press Releases

Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
A Guide to Philadelphia’s Top Luxury Wellness & Recovery Spots

A Guide to Philadelphia’s Top Luxury Wellness & Recovery Spots

Inside the Newsroom: EIN Presswire Launches Series on What Journalists Really Look for in Press Releases
Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results
Digital health tools do not always build confidence for dementia caregivers
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025
Azurity Pharmaceuticals Announces Ferabright<sup>TM</sup> (ferumoxytol injection) Now Available in the U.S. for Magnetic Resonance Imaging of the Brain
The American Institute of Health Care Professionals Launches New Certification Program in Managed Health Care Consulting
INVESTOR ALERT: Camping World Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
ACTG Announces Publication of STOMP Results in the New England Journal of Medicine
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
AQ USA Inc., d.b.a Ross Healthcare Inc. - 719517 - 02/12/2026

AQ USA Inc., d.b.a Ross Healthcare Inc. - 719517 - 02/12/2026

INVESTOR DEADLINE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law
Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026
Merit Medical Reports Fourth Quarter and Full Year 2025 Results and Issues Fiscal Year 2026 Guidance
Professional Golfer Max Homa Joins Arcutis’ Free to Be Me Campaign, Urging Individuals with Seborrheic Dermatitis to Tee Up a Conversation with Their Healthcare Provider About Long-Term Treatments
Emerald Analysis of 25,000 Biomarker Tests Reveals Hidden Health Risks Across the UK
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions